These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 27886620)
41. The Search for a Subtype-Selective PET Imaging Agent for the GABA Lin SF; Bois F; Holden D; Nabulsi N; Pracitto R; Gao H; Kapinos M; Teng JK; Shirali A; Ropchan J; Carson RE; Elmore CS; Vasdev N; Huang Y Mol Imaging; 2017; 16():1536012117731258. PubMed ID: 28929924 [TBL] [Abstract][Full Text] [Related]
42. Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity: a comparative positron emission tomography/magnetic resonance imaging study in early ischemic stroke. Heiss WD; Sobesky J; Smekal Uv; Kracht LW; Lehnhardt FG; Thiel A; Jacobs AH; Lackner K Stroke; 2004 Aug; 35(8):1892-8. PubMed ID: 15218157 [TBL] [Abstract][Full Text] [Related]
45. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Heiss WD; Grond M; Thiel A; Ghaemi M; Sobesky J; Rudolf J; Bauer B; Wienhard K Stroke; 1998 Feb; 29(2):454-61. PubMed ID: 9472889 [TBL] [Abstract][Full Text] [Related]
46. [11C]Flumazenil PET in patients with epilepsy with dual pathology. Juhász C; Nagy F; Muzik O; Watson C; Shah J; Chugani HT Epilepsia; 1999 May; 40(5):566-74. PubMed ID: 10386525 [TBL] [Abstract][Full Text] [Related]
47. Use of a standardized uptake value for parametric in vivo imaging of benzodiazepine receptor distribution on [11C]flumazenil brain PET. Tsukamoto M; Katoh C; Shiga T; Kaji T; Kuge Y; Nakada K; Tamaki N Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):846-51. PubMed ID: 14985864 [TBL] [Abstract][Full Text] [Related]
48. Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy. Juhász C; Muzik O; Chugani DC; Shen C; Janisse J; Chugani HT Epilepsia; 2001 Oct; 42(10):1320-6. PubMed ID: 11737167 [TBL] [Abstract][Full Text] [Related]
49. Central benzodiazepine/gamma-aminobutyric acid A receptors in idiopathic generalized epilepsy: an [11C]flumazenil positron emission tomography study. Koepp MJ; Richardson MP; Brooks DJ; Cunningham VJ; Duncan JS Epilepsia; 1997 Oct; 38(10):1089-97. PubMed ID: 9579955 [TBL] [Abstract][Full Text] [Related]
50. [11C]flumazenil PET: activity images versus parametric images for the detection of neocortical epileptic foci. Niimura K; Muzik O; Chugani DC; Shen C; Chugani HT J Nucl Med; 1999 Dec; 40(12):1985-91. PubMed ID: 10616875 [TBL] [Abstract][Full Text] [Related]
51. I-123 iomazenil single photon emission computed tomography for detecting loss of neuronal integrity in patients with traumatic brain injury. Abiko K; Ikoma K; Shiga T; Katoh C; Hirata K; Kuge Y; Kobayashi K; Tamaki N EJNMMI Res; 2017 Dec; 7(1):28. PubMed ID: 28337724 [TBL] [Abstract][Full Text] [Related]
52. Metabolite analysis of [11C]flumazenil in human plasma: assessment as the standardized value for quantitative PET studies. Ishiwata K; Itou T; Ohyama M; Yamada T; Mishina M; Ishii K; Nariai T; Sasaki T; Oda K; Toyama H; Senda M Ann Nucl Med; 1998 Feb; 12(1):55-9. PubMed ID: 9559964 [TBL] [Abstract][Full Text] [Related]
53. Ex vivo characterization of neuroinflammatory and neuroreceptor changes during epileptogenesis using candidate positron emission tomography biomarkers. Bascuñana P; Gendron T; Sander K; Jahreis I; Polyak A; Ross TL; Bankstahl M; Arstad E; Bankstahl JP Epilepsia; 2019 Nov; 60(11):2325-2333. PubMed ID: 31571210 [TBL] [Abstract][Full Text] [Related]
55. The neuronal component of gray matter damage in multiple sclerosis: A [(11) C]flumazenil positron emission tomography study. Freeman L; Garcia-Lorenzo D; Bottin L; Leroy C; Louapre C; Bodini B; Papeix C; Assouad R; Granger B; Tourbah A; Dollé F; Lubetzki C; Bottlaender M; Stankoff B Ann Neurol; 2015 Oct; 78(4):554-67. PubMed ID: 26292991 [TBL] [Abstract][Full Text] [Related]
56. Acute in vivo effect of valproic acid on the GABAergic system in rat brain: A [ Bertelsen F; Landau AM; Vase KH; Jacobsen J; Scheel-Krüger J; Møller A Brain Res; 2018 Feb; 1680():110-114. PubMed ID: 29258847 [TBL] [Abstract][Full Text] [Related]